NCT05247684 2026-03-05
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC
Akeso
Phase 2 Active not recruiting
Clinical Trials
6 trialsNCT06161441 2026-01-12
A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
Regeneron Pharmaceuticals
Phase 2 Active not recruiting
NCT07038460 2025-06-26
NEO-LISI
Guangdong Provincial People's Hospital
Phase 2 Not yet recruiting
NCT06946836 2025-04-27
Neoadjuvant
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Not yet recruiting
NCT06485557 2024-07-03
A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC
Tang-Du Hospital
Phase 3 Not yet recruiting
NCT06169956 2024-04-18
NENI
Bristol-Myers Squibb
Recruiting